ArticleExperimental hematology & oncology2024

Anti-TIM3 chimeric antigen receptor-natural killer cells preferentially target primitive acute myeloid leukemia cells with minimal fratricide and exhaustion.

Phatchanat Klaihmon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.